Tumor-killing virus selectively targets diseased brain cellsFebruary 20, 2008New findings show that a specialized virus with the ability to reproduce its tumor-killing genes can selectively target tumors in the brains of mice and eliminate them. Healthy brain tissue remained virtually untouched, according to a Feb. 20 report in The Journal of Neuroscience. With more research, the technique could one day offer a novel way of treating brain cancer in humans. "Most importantly, this study finds that the virus can penetrate into the brain, where it even reaches cells that have migrated away from the main tumor," says Harald Sontheimer, PhD, of the University of Alabama at Birmingham, who was not affiliated with the study. "Assuming that the virus behaves similarly in humans, in the future, it may provide a novel and highly efficacious way to treat resistant tumors." The study is the culmination of six years of basic research into the fundamental processes of viruses and the cells they target, conducted by senior author Anthony van den Pol, PhD, and his team at Yale University School of Medicine. They set out to test the vesicular stomatis virus, which was selected for its ability to attack brain tumors and leave healthy tissue largely uninfected.
Tumor cells from brain cancers commonly found both in people and in mice were implanted into immune-compromised mice, which then received an injection of the virus in the tail. By viewing fluorescent proteins embedded in both tumor and virus cells in the brains of living mice, van den Pol's team watched as the virus infected multiple sites in the brain, spreading across an entire tumor within three days, killing tumor cells in its wake. The virus did not target normal mouse tissue or non-cancerous human brain cells transplanted into the mouse brain, the team found. They speculated that, unlike those in healthy brain tissue, blood vessels within brain tumors may leak, allowing the virus to cross the usually impenetrable protective barrier around the brain. The virus was equally effective in destroying tissue from cancers that start in the breast or lung and spread to the brain-the two cancers most likely to metastasize to the brain-and targeted tumors at different sites throughout the body. Each year in the United States, more than 20,000 new cases of brain or nervous system cancers are diagnosed, according to the National Cancer Institute. Future research will focus on understanding potential safety risks, such as whether the virus could eventually infect normal brain cells, as well exploring potential changes to the virus that could mitigate such risk. "We have some ideas for making the virus safer in the human brain," says van den Pol. "This is important to prevent the virus from potentially infecting normal brain cells after it has targeted the brain tumor." Society for Neuroscience Science News and Science Current Events Tag Cloud This tag cloud is a visual representation of term frequencies of random science news topics with common terms grouped together and emphasized by their display size. Polymerase Resveratrol Amazon rainforest HIV prevention Mental Disorder Depleted Uranium Statin Trastuzumab Amniotic Fluid Earthquake Stroke Patients Particle Accelerator Lymphedema Solar Energy Testicular Cancer Gravitational Wave Proteomics Suicide Digital Camera Macular Degeneration Diabetes Combination Therapy HIV-1 Radiation Therapy Liver Cells
See More: Science News Tags | |||||||||||||||||||||
|
Related Tumor Current Events and Tumor News Articles Newly appreciated membrane estrogen receptor important therapeutic target for breast cancer New research at Rhode Island Hospital has uncovered the biological effects of a novel membrane estrogen receptor, a finding that has potential implications for hormonal therapy for breast cancer. Researchers testing virus-gene therapy combination against melanoma Researchers at the Moores UCSD Cancer Center are injecting a modified herpes virus into melanoma tumors, hoping to kill the cancer cells while also bolstering the body's immune defenses against the disease. Study shows PET can measure effectiveness of novel breast cancer treatment A new study published in the July issue of The Journal of Nuclear Medicine shows that positron emission tomography (PET) scans in mice can be used to determine whether a novel type of breast cancer treatment is working as intended. Study identifies biomarker that safely monitors tumor response to new brain cancer treatment A specific biomarker, a protein released by dying tumor cells, has been identified as an effective tool in an animal model to gauge the response to a novel gene therapy treatment for glioblastoma mulitforme. Colorectal cancer Previously, only a few genes had been associated with the formation of metastases in colorectal cancer. Now, researchers of the Max Delbrück Center for Molecular Medicine (MDC) Berlin-Buch and Charité - University Medicine Berlin, Germany, have identified 115 genes that are disregulated both in the primary tumor and in its metastases. Second gene linked to familial testicular cancer Specific variations or mutations in a particular can gene raise a man's risk of familial, or inherited, testicular germ-cell cancer, the most common form of this disease. Novel epigenetic markers of melanoma may herald new treatments for patients Melanoma is the most serious form of skin cancer, diagnosed in more than 50,000 new patients in the United States annually. While the rate of incidences continues to rise, survival rate has not improved and the race is on to find the genetic and cellular changes driving melanoma and to devise new means of detection and treatment. Researchers pinpoint a new enemy for tumor-suppressor p53 Researchers at The University of Texas M. D. Anderson Cancer Center have identified a protein that marks the tumor suppressor p53 for destruction, providing a potential new avenue for restoring p53 in cancer cells. Effective pain treatment for cancer patients? Cancer patients often suffer from severe pain that cannot be effectively treated with conventional medication. What should a teenage girl do if she finds a lump in her breast? If a lump is found in the breast of an adolescent girl, she often will undergo an excisional biopsy. More Tumor Current Events and Tumor News Articles |
|||||||||||||||||||||
|
|||||||||||||||||||||
|
|||||||||||||||||||||